DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Desmoteplase is an investigational drug.
There have been 6 clinical trials for Desmoteplase. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Stroke, Ischemia, and Cerebral Infarction. The leading clinical trial sponsors are H. Lundbeck A/S, PAION Deutschland GmbH, and Forest Laboratories.
Recent Clinical Trials for Desmoteplase
|Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke||Lundbeck Japan K. K.||Phase 2|
|Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)||H. Lundbeck A/S||Phase 3|
|Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke||H. Lundbeck A/S||Phase 3|